The laboratory, which is the first facility dedicated exclusively to the study of plant-based psychedelics, is being launched in partnership with University of the West Indies TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ FieldTrip“), a leader in the development and delivery of psychedelic therapies, is pleased to announce the official…

Source

Previous articleCOMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
Next articleFeb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%